Ligand validation:3AYM

RET: RETINAL

RET is a Ligand Of Interest in 3AYM designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3AYM_RET_B_1000	52%	12%	0.221	0.981	1.97	2.05	5	8	1	0	100%	0.9524
3AYM_RET_A_1000	49%	17%	0.235	0.985	1.82	1.76	2	5	1	0	100%	0.9524
3AYN_RET_B_1000	96%	25%	0.058	0.969	1.93	1.14	4	4	1	0	100%	0.9524
4WW3_RET_B_402	49%	13%	0.221	0.968	1.68	2.31	5	8	0	0	100%	0.9524
2Z73_RET_B_1000	49%	18%	0.227	0.974	1.81	1.69	6	6	0	0	100%	0.9524
2ZIY_RET_A_380	0%	11%	0.793	0.757	2.15	2.08	5	7	13	0	100%	0.9524
3UTY_RET_A_301	100%	5%	0.028	0.992	2.48	2.7	6	12	2	0	100%	0.9524
3UTX_RET_B_301	100%	6%	0.042	0.988	2.42	2.7	5	12	4	0	100%	0.9524
7XJE_RET_A_301	99%	6%	0.048	0.983	1.99	2.98	4	14	1	0	100%	0.9524
5G28_RET_A_1268	97%	23%	0.051	0.968	1.29	1.84	3	5	0	0	100%	0.9524
7XJC_RET_A_301	97%	10%	0.067	0.98	1.93	2.43	2	14	0	0	100%	0.7752

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.